|
Lederberg, J.
(1959) Genes and antibodies. Do antigens bear instructions for
antibody specificity or do they select cell lines that arise by
mutation? Science 129, 1649-1653.
Eisen, H. N. &
Siskind, G. W. (1964) Variations in affinities of antibodies
during the immune response. Biochemistry 3, 996-1008.
Weigert, M. G.,
Cesari, I. M., Yonkovich, S. J. & Cohn, M. (1970) Variability
in the lambda light chain sequences of mouse antibody. Nature 228,
1045-1047.
|
Affinity
maturation. In an immune response, antibodies produced after
an animal is first exposed to an antigen generally react weakly.
However, the initial interaction starts a process of cell
proliferation and hypermutation in the immunoglobulin loci. The
orthodox view is that antibody mutations causing an increase in
antigen affinity confer a selective advantage on a lymphocyte. In
a Darwinian process, these cells capture antigen and proliferate
under the action of cytokines and helper T-cells, while cells that
are unable to accumulate antigen do not receive stimulatory
signals and are eliminated. Memory cells encoding antibodies that
have extensively mutated and acquired a high degree of
complementarity to antigen persist for the lifetime of an
organism, and can be mobilized rapidly in the event of re-exposure
to the same antigen. This overall process is known as affinity
maturation of the immune response. Evidence for this model came in
the 1960s from Eisen's quantitative measure of changing hapten
affinity and Weigert's demonstration of somatic mutation in mouse
lambda chains.
|
Kaartinen, M.,
Griffiths, G. M., Markham, A. F. & Milstein, C. (1983) Nature
304, 320-324.
Griffiths, G. M., Berek, C., Kaartinen, M. & Milstein, C.
(1984) Nature 312, 271-275.
Foote, J. & Milstein, C. (1991) Kinetic maturation of an
immune response. Nature 352, 530-532.
|
Doubts about affinity maturation. Antigen capture is clearly a
key event in B-cell ontogeny, but the theory that maturation is
affinity-based has come into conflict with new data.
Hybridomas derived
from different stages of the murine immune response to the hapten
2-phenyl-5-oxazolone (Ox) exclusively used a single pair of
antibody heavy and light chain variable genes in the early
response, and these genes mutated systematically to give higher
affinity. This "canonical" anti-Ox structure was
replaced in later response stages by heterogeneous gene usage.
This repertoire shift occurred without a concomitant increase in
hapten affinity, suggesting the action of a different selective
factor. JF, while a postdoc in César Milstein's lab, measured the
hapten binding kinetics of each monoclonal antibody in the Ox
collection, and found that many of the antibodies with mediocre
affinity that emerged in the late response had an
order-of-magnitude faster rate constant than the starting
repertoire. The repertoire shift could then be explained by
postulating that binding an antigen rapidly, as well as with high
affinity, was a factor in lymphocyte selection driving a
heretofore unrecognized process of "kinetic" maturation.
A number of
subsequent studies on protein antigens have exposed difficulties
with affinity-based selection:
|
|
Newman, M. A., Mainhart, C. R., Mallet, C. P., Lavoie, T. B. &
Smith-Gill, S. J. (1992) J. Immunol. 149, 3260-3272.
|
•Smith-Gill's laboratory found that anti-lysozyme hybridomas
made at different times after immunization showed no evidence of
increasing affinity over the course of the immune response.
|
|
Mantovani, L., Wilder, R. L. & Casali, P. (1993) J. Immunol.
151, 473-488.
|
•Casali's group, studying human rheumatoid factors, found little
affinity difference between molecules that clearly had a high
number of antigen-selected somatic mutations.
|
|
Mukherjee, J., Casadevall, A. & Scharff, M. D. (1993) J. Exp.
Med. 177, 1105-1116.
|
•Scharff's group, working on immunity to cryptococcal infection,
again found discrepancies between somatic mutation and affinity
increase.
|
|
Roost, H.-P., Bachman, M. F., Haag, A., Kalinke, U., Pliska, V.,
Hengartner, H. & Zinkernagel, R. M. (1995) Proc. Natl. Acad.
Sci. USA 92, 1057-1061.
Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart,
C., Roost, H., Aguet, M., Hengartner , H. & Zinkernagel, R. M.
(1997) Science 276, 2024-2027.
|
•Zinkernagel's laboratory, looking at the murine immune response
to vesicular stomatitis virus infection, made a seminal finding:
that on-rate closely correlated with virus neutralization, moreso
than did affinity. In this case also, affinity maturation was not
evident. A subsequent paper showed that affinity was only a
marginal factor in virus neutralization; any antibody above a
certain affinity threshold was potentially neutralizing.
|
|
Goldbaum, F. A., Cauerhff, A., Velikovsky, C. A., Llera, A. S.,
Riottot, M. M. & Poljak, R. J. (1999) J. Immunol. 162,
6040-6045.
England, P.,
Nageotte, R., Renard, M., Page, A. L. & Bedouelle, H. (1999)
J. Immunol. 162, 2129Ð2136.
|
Some clarification has emerged from recent studies on the response
to hen egg lysozyme. Roberto Poljak's group, which has generated
many anti-lysozyme monoclonals, did a comprehensive survey of
kinetic and affinity properties of their collection, and again
found that high affinity was the rule for IgGÕs, regardless of
immune response stage. Bedouelle's group examined one of these
antibodies, identified germline genes from which it originated,
and re-created the probable precursor, devoid of any somatic point
mutations. The germline precursor proved to have a 60-fold lower
affinity than the mature antibody, attributable largely to a
single residue difference. The implication of Bedouelle's paper is
that maturation does occur, and that the foregoing studies of the
immune response to protein antigens simply failed to detect it,
because the process happens in a shorter time window than anyone
realized.
|
|
(Sure. Why not call it that.)
Foote, J. &
Eisen, H. N. (1995) Kinetic and affinity limits on antibodies
produced during immune responses. Proc. Natl. Acad. Sci. USA 92,
1054-1056.
|
Foote-Eisen Model. The failure of affinity maturation to
explain the course of immune responses to protein antigens led JF
and Herman Eisen to propose a new model, which appeared as a
Commentary along with Zinkernagel's paper. In the model, affinity
does not increase without limit, but is governed by separate
kinetic limits on two biological events:
1. The on-rate
constant (kon) determines the efficiency of initial
antigen capture, and is in turn limited by the rate of antigen
diffusion. Somatic mutation can improve antigen capture by
generating antibodies with kon up to the diffusion limit, but
not beyond. Numerically, maximum kon is about 106
M-1 s-1 for antibodies binding small
protein antigens, with exceptional cases (probably utilizing
electrostatic interactions) up to 107.
2. The off-rate
constant (koff) controls whether after initial
capture an antigen is more likely to be released or
internalized. Decreasing koff increases antigen
residence time on a B cell's surface, hence increases the
probability of internalization. However, beyond a time period
determined by membrane dynamics, very approximately 1 hour,
internalization becomes a certainty, and is unaffected by
further decreases in off-rate. Thus, the optimum kinetic
phenotype of an antigen-specific B cell should also show a koff
slow enough to guarantee that antigen capture wll be followed by
internalization.
|
 |
Hapten and protein antigens. Haptens are small, generally
aromatic, molecules that form limited antigenic determinants when
conjugated to a protein carrier. Antibodies to conjugated hapten
structures are easily raised, and the interaction of these
antibodies with free hapten is readily quantified by spectrometric
or radioactive assays. Unfortunately, conventional hapten
conjugates do not allow meaningful analysis of the interaction of
an antibody with the actual immunogen used to induce that
antibody. Conventional conjugates are heterogeneous ensembles of
carrier molecules with different numbers of haptens distributed
over structurally diverse attachment sites. This polymorphism
precludes assigning a preparation an unambiguous chemical
concentration that could be used with the Mass Action Law to
interpret physical data. Such analysis is crucial to interpret
changes in the antibody repertoire that occur during an immune
response. Use of native protein antigens in place of conjugates
does not offer a solution. Detection and kinetic measurement of
the interaction of native proteins with antibody is problematical,
and the lack of a detachable hapten ensures that analysis of the
immune response to the entire protein surface will be a task of
great complexity.
|
|